Bone marrow studies of patients suffering from POEMS syndrome shows lymphoid aggregates rimmed by monotypic or polytypic plasma cells.
Diffuse infiltration of light chain restricted plasma cells leads to development of predominantly sclerotic bone lesions. This is in contrast with myeloma patients where there is a predominance of lyticbone lesions. The bony lesions are primarily restricted to the axial and proximal appendicular skeleton.[3][4][5]
The monoclonalplasma cell proliferation in POEMS syndrome is thought to play a major role in overproduction of numerous pro-angiogenic and pro-inflammatory cytokines.
The hypercytokinetic state induced in patients of POEMS syndrome is thought to drive the disease process. The following cytokines are overproduced:[6]
VEGF is a pro-angiogenic cytokine that promotes neovascularization. It is thought to be overproduced in POEMS syndrome and can serve as a marker of disease activity in these patients.
Since VEGF is expressed by osteoblasts and has a role in osteoblastic differentiation, the bone condensation (sclerosis) seen in POEMS syndrome may also be partly attributed to increased circulating VEGF levels.[17]
As a result, there is accumulation of fluid in the extracellular compartment and the resultant edema seen in patients of POEMS syndrome.
Alteration of Blood-Nerve Barrier and Secondary Axonal Degenration
Unregulated neovascularization also leads to disruption of the blood-nerve barrier in the peripheral nervous system (PNS), which subsequently results in endoneural edema. The edema compresses the nerves and eventually leads to secondary axonal degeneration.
A normal liver is less than 16 cm on ultrasound evaluation. Hepatomegaly may be found during physical examination or on imaging studies. Imaging is more accurate in determining liver size.[21][22]
↑Aggarwal S, Goulatia RK, Sood A, Prasad K, Ahuja GK, Mitchell MJ, Kumar A (August 1990). "POEMS syndrome: a rare variety of plasma cell dyscrasia". AJR Am J Roentgenol. 155 (2): 339–41. doi:10.2214/ajr.155.2.2115264. PMID2115264.
↑Wang C, Su W, Zhang W, Di Q, Duan MH, Ji W, Cao XX, Zhou DB, Li J (July 2014). "Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome". Ann. Hematol. 93 (7): 1201–6. doi:10.1007/s00277-014-2019-y. PMID24482101.
↑Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL (July 1980). "Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature". Medicine (Baltimore). 59 (4): 311–22. PMID6248720.
↑Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y (June 1984). "The Crow-Fukase syndrome: a study of 102 cases in Japan". Neurology. 34 (6): 712–20. PMID6539431.
↑Resnick D, Greenway GD, Bardwick PA, Zvaifler NJ, Gill GN, Newman DR (July 1981). "Plasma-cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes: the POEMS syndrome. Distinctive radiographic abnormalities". Radiology. 140 (1): 17–22. doi:10.1148/radiology.140.1.7244223. PMID7244223.
↑Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M (June 1992). "Castleman's disease in POEMS syndrome with elevated interleukin-6". Cancer. 69 (11): 2697–703. PMID1571900.
↑Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y, Nasu S, Nakaseko C, Takano S, Yoshitomi H, Miyazaki M, Nomura F, Kuwabara S (August 2012). "Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome". Neurology. 79 (6): 575–82. doi:10.1212/WNL.0b013e318263c42b. PMID22843279.
↑Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Watanabe H, Tanaka F, Doyu M, Sobue G (October 2008). "Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome". J. Neurol. Neurosurg. Psychiatry. 79 (10): 1171–9. doi:10.1136/jnnp.2007.135681. PMID18356256.
↑Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I (March 1996). "Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome". Lancet. 347 (9002): 702. PMID8596427.
↑Yoshizaki K, Nakagawa T, Kaieda T, Muraguchi A, Yamamura Y, Kishimoto T (March 1982). "Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors". J. Immunol. 128 (3): 1296–301. PMID6799573.
↑Pei G, Yang D, Sun J, Luo Y, Yan J, Chen Y (2015). "Cardiac Involvement in a Patient With POEMS Syndrome Detected Using Cardiac Magnetic Resonance Imaging". Int Heart J. 56 (5): 571–3. doi:10.1536/ihj.15-038. PMID26346518.
↑Gremain V, Litrowski N, Boulard C, Marguet F, Courville P, Zarnitsky C, Langlois V (January 2018). "Necrotizing autoimmune myopathy associated with POEMS syndrome report". QJM. 111 (1): 49–50. doi:10.1093/qjmed/hcx197. PMID29088446.